ImmuneSense COVID-19 Variant Study
Clinical trial NCT05054088 · COMPLETED
Trial details
- NCT number
- NCT05054088
- Sponsor
- Adaptive Biotechnologies
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-10-12
- Primary completion
- 2022-07-20
- Enrollment
- 203
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.